Young K W, Challiss R A, Nahorski S R, MacKrill J J
Department of Cell Physiology and Pharmacology, Medical Sciences Building, University of Leicester, P.O. Box 138, University Road, Leicester LE1 9HN, U.K.
Biochem J. 1999 Oct 1;343 Pt 1(Pt 1):45-52.
Extracellular application of lysophosphatidic acid (LPA) elevated intracellular Ca(2+) concentration (Ca(2+)) in human SH-SY5Y neuroblastoma cells. The maximal response to LPA occurred between 0. 1 and 1 microM, at which point Ca(2+) was increased by approx. 500 nM. This increase was of similar magnitude to that caused by the muscarinic acetylcholine receptor agonist methacholine (MCh), although the initial rate of release by LPA was slower. Both LPA and MCh released Ca(2+) from intracellular stores, as assessed by inhibition of their effects by thapsigargin, a blocker of endoplasmic reticular Ca(2+) uptake, and by the persistence of their action in nominally Ca(2+)-free extracellular medium. Similarly, both agonists appeared to stimulate store-refilling Ca(2+) entry. MCh produced a marked elevation in cellular Ins(1,4,5)P(3) and stimulated [(3)H]InsP accumulation in the presence of Li(+). In contrast, LPA failed to stimulate detectable phosphoinositide turnover. Chronic down-regulation of Ins(1,4,5)P(3) receptor (InsP(3)R) proteins with MCh did not affect Ca(2+) responses to LPA. In addition, heparin, a competitive antagonist of InsP(3)Rs, blocked Ca(2+)-mobilization in permeabilized SH-SY5Y cells in response to MCh or exogenously added Ins(1,4,5)P(3), but failed to inhibit Ca(2+)-release induced by LPA. Elevation of Ca(2+) elicited by LPA was blocked by guanosine 5'-[beta-thio]-diphosphate, indicating that this agonist acts via a G-protein-coupled receptor. However, pertussis toxin was without effect on LPA-evoked Ca(2+) responses, suggesting that G(i/o)-proteins were not involved. In the absence of extracellular Ca(2+), N,N-dimethylsphingosine (DMS, 30 microM), a competitive inhibitor of sphingosine kinase, blocked LPA-induced Ca(2+) responses by almost 90%. In addition, MCh-induced Ca(2+) responses were also diminished by the addition of DMS, although to a lesser extent than with LPA. We conclude that LPA mobilizes intracellular Ca(2+)-stores in SH-SY5Y cells independently of the generation and action of Ins(1,4,5)P(3). Furthermore, the Ca(2+)-response to LPA appears to be dependent on sphingosine kinase activation and the potential generation of the putative second messenger sphingosine 1-phosphate.
在人源SH-SY5Y神经母细胞瘤细胞中,细胞外施加溶血磷脂酸(LPA)可提高细胞内钙离子浓度([Ca(2+)]i)。对LPA的最大反应出现在0.1至1微摩尔之间,此时[Ca(2+)]i增加了约500纳摩尔。尽管LPA的初始释放速率较慢,但这种增加的幅度与毒蕈碱型乙酰胆碱受体激动剂乙酰甲胆碱(MCh)引起的幅度相似。通过内质网钙摄取阻滞剂毒胡萝卜素对其作用的抑制,以及在名义上无钙的细胞外培养基中其作用的持续性评估,LPA和MCh均从细胞内储存中释放钙离子。同样,两种激动剂似乎都刺激储存再填充性钙离子内流。MCh在存在Li(+)的情况下使细胞内肌醇-1,4,5-三磷酸(Ins(1,4,5)P(3))显著升高,并刺激[(3)H]InsP积累。相比之下,LPA未能刺激可检测到的磷脂酰肌醇转换。用MCh长期下调Ins(1,4,5)P(3)受体(InsP(3)R)蛋白并不影响对LPA的钙离子反应。此外,肝素是InsP(3)Rs的竞争性拮抗剂,可阻断通透的SH-SY5Y细胞中对MCh或外源添加的Ins(1,4,5)P(3)的钙离子动员,但未能抑制LPA诱导的钙离子释放。LPA引起的[Ca(2+)]i升高被鸟苷5'-[β-硫代]二磷酸阻断,表明该激动剂通过G蛋白偶联受体起作用。然而,百日咳毒素对LPA诱发的[Ca(2+)]i反应没有影响,这表明G(i/o)蛋白不参与其中。在无细胞外钙离子的情况下,鞘氨醇激酶的竞争性抑制剂N,N-二甲基鞘氨醇(DMS,30微摩尔)可使LPA诱导的钙离子反应阻断近90%。此外,添加DMS也会使MCh诱导的钙离子反应减弱,尽管程度小于LPA。我们得出结论,LPA在SH-SY5Y细胞中动员细胞内钙离子储存,独立于Ins(1,4,5)P(3)的产生和作用。此外,对LPA的钙离子反应似乎依赖于鞘氨醇激酶激活以及推定的第二信使鞘氨醇-1-磷酸的潜在产生。